Indo Amines Ltd
NSE:INDOAMIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indo Amines Ltd
NSE:INDOAMIN
|
IN |
|
A
|
Allianz Malaysia Bhd
KLSE:ALLIANZ
|
MY |
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
US |
|
Harland & Wolff Group Holdings PLC
LSE:HARL
|
UK |
Income Statement
Earnings Waterfall
Indo Amines Ltd
Income Statement
Indo Amines Ltd
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
119
|
0
|
0
|
0
|
149
|
0
|
0
|
0
|
203
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
9 056
N/A
|
7 860
-13%
|
10 443
+33%
|
9 247
-11%
|
9 242
0%
|
9 450
+2%
|
9 304
-2%
|
9 422
+1%
|
9 250
-2%
|
9 435
+2%
|
9 650
+2%
|
9 813
+2%
|
10 462
+7%
|
10 787
+3%
|
11 011
+2%
|
11 089
+1%
|
11 275
+2%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(6 238)
|
(5 895)
|
(7 260)
|
(6 501)
|
(6 469)
|
(7 117)
|
(6 475)
|
(6 583)
|
(6 395)
|
(7 211)
|
(6 671)
|
(6 664)
|
(7 145)
|
(7 972)
|
(7 430)
|
(7 408)
|
(7 538)
|
|
| Gross Profit |
2 818
N/A
|
1 966
-30%
|
3 183
+62%
|
2 746
-14%
|
2 773
+1%
|
2 333
-16%
|
2 828
+21%
|
2 840
+0%
|
2 850
+0%
|
2 224
-22%
|
2 973
+34%
|
3 144
+6%
|
3 318
+6%
|
2 815
-15%
|
3 581
+27%
|
3 681
+3%
|
3 736
+1%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(2 210)
|
(1 584)
|
(2 646)
|
(2 266)
|
(2 258)
|
(1 606)
|
(2 106)
|
(2 063)
|
(2 074)
|
(1 575)
|
(2 279)
|
(2 420)
|
(2 555)
|
(1 968)
|
(2 715)
|
(2 744)
|
(2 802)
|
|
| Selling, General & Administrative |
(398)
|
(1 443)
|
(421)
|
(351)
|
(364)
|
(1 432)
|
(399)
|
(416)
|
(426)
|
(1 422)
|
(474)
|
(499)
|
(529)
|
(1 797)
|
(571)
|
(597)
|
(630)
|
|
| Depreciation & Amortization |
(133)
|
(141)
|
(181)
|
(159)
|
(168)
|
(173)
|
(169)
|
(160)
|
(154)
|
(153)
|
(158)
|
(167)
|
(172)
|
(170)
|
(179)
|
(188)
|
(199)
|
|
| Other Operating Expenses |
(1 679)
|
0
|
(2 044)
|
(1 757)
|
(1 726)
|
0
|
(1 539)
|
(1 487)
|
(1 493)
|
0
|
(1 645)
|
(1 753)
|
(1 854)
|
0
|
(1 965)
|
(1 959)
|
(1 973)
|
|
| Operating Income |
609
N/A
|
381
-37%
|
538
+41%
|
480
-11%
|
515
+7%
|
727
+41%
|
722
-1%
|
777
+8%
|
782
+1%
|
649
-17%
|
701
+8%
|
729
+4%
|
762
+4%
|
847
+11%
|
866
+2%
|
937
+8%
|
935
0%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(159)
|
(71)
|
(174)
|
(148)
|
(157)
|
(169)
|
(194)
|
(213)
|
(223)
|
(107)
|
(220)
|
(218)
|
(218)
|
(118)
|
(231)
|
(236)
|
(237)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
159
|
34
|
110
|
58
|
32
|
10
|
78
|
123
|
135
|
19
|
195
|
193
|
198
|
41
|
235
|
231
|
229
|
|
| Pre-Tax Income |
609
N/A
|
345
-43%
|
474
+37%
|
390
-18%
|
390
0%
|
568
+46%
|
605
+7%
|
687
+13%
|
694
+1%
|
583
-16%
|
676
+16%
|
706
+4%
|
743
+5%
|
769
+4%
|
870
+13%
|
931
+7%
|
927
-1%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(170)
|
(115)
|
(159)
|
(137)
|
(129)
|
(159)
|
(159)
|
(171)
|
(184)
|
(153)
|
(175)
|
(185)
|
(208)
|
(210)
|
(214)
|
(233)
|
(223)
|
|
| Income from Continuing Operations |
439
|
230
|
315
|
253
|
260
|
409
|
446
|
516
|
510
|
430
|
501
|
520
|
535
|
559
|
655
|
699
|
704
|
|
| Income to Minority Interest |
0
|
(2)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
|
| Net Income (Common) |
279
N/A
|
228
-18%
|
313
+37%
|
251
-20%
|
258
+3%
|
404
+57%
|
441
+9%
|
512
+16%
|
506
-1%
|
427
-15%
|
499
+17%
|
518
+4%
|
533
+3%
|
552
+4%
|
649
+17%
|
692
+7%
|
698
+1%
|
|
| EPS (Diluted) |
3.88
N/A
|
3.26
-16%
|
4.48
+37%
|
3.58
-20%
|
3.52
-2%
|
5.78
+64%
|
6.03
+4%
|
7.5
+24%
|
6.56
-13%
|
6.05
-8%
|
6.98
+15%
|
7.36
+5%
|
7.16
-3%
|
7.61
+6%
|
8.86
+16%
|
9.55
+8%
|
9.52
0%
|
|